CN105288486A - Uterine fibroid treating traditional Chinese medicine composition - Google Patents

Uterine fibroid treating traditional Chinese medicine composition Download PDF

Info

Publication number
CN105288486A
CN105288486A CN201510832754.8A CN201510832754A CN105288486A CN 105288486 A CN105288486 A CN 105288486A CN 201510832754 A CN201510832754 A CN 201510832754A CN 105288486 A CN105288486 A CN 105288486A
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
rhizoma
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510832754.8A
Other languages
Chinese (zh)
Inventor
宋妮妮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510832754.8A priority Critical patent/CN105288486A/en
Publication of CN105288486A publication Critical patent/CN105288486A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to the field of drug formulas, particularly to a uterine fibroid treating traditional Chinese medicine composition, which is prepared from the following bulk drugs by weight: 13-18 parts of angelica, 13-18 parts of foeniculum vulgare mill, 17-23 parts of corydalis turtschaninovii, 17-23 parts of ligusticum chuanxiong hort, 12-16 parts of radix paeoniae rubra, 3-7 parts of typha angustifolia l, 3-7 parts of cyperus rotundus l, 18-25 parts of appendiculate cremastra pseudobulb, 13-17 parts of safflower, 28-34 parts of myrrh, 10-14 parts of cyathula officinalis kuan, 14-16 parts of fructus alpinae oxyphyllae, 14-16 parts of strychnos nux-vomica l, 8-11 parts of hedyotis diffusa willd, 10-13 parts of faeces trogopterpri, 28-34 parts of curcuma zedoaria, 8-12 parts of scorpion, 8-12 parts of milkvetch root, 13-17 parts of radix linderae, 16-20 parts of cassiatwig, and 7-10 parts of semen ziziphi spinosae, wherein the 21 bulk drugs are mixed, the mixture is soaked with water, boiling is performed, and the residue is removed to obtain the filtrate.

Description

The Chinese medicine composition for the treatment of hysteromyoma
Technical field
The present invention relates to a kind of Chinese patent medicine preparation, specifically a kind of Chinese medicine composition for the treatment of hysteromyoma.
Background technology
As everyone knows, hysteromyoma is the modal a kind of tumors of female sex organs.Current pathogenic factor is still not clear, if but timely treatment can cause the harm such as female acyesis, miscarriage, frequent micturition, dysuria, and also can there is malignant change in minority, be a large killer of women's health.Clinical manifestation is mainly: menoxenia, abdominal part swell companion bearing down, leucorrhea many and companion abnormal flavour, lower abdomen falling inflation, aching pain in waist and back etc.Adopt excision at present, but excision one side somewhat expensive is painful large, only can excise established tumor on the other hand, can not improve the easy blastomogenic body constitution of patient, cannot effect a radical cure more.Medicine is hormones mainly, and the toxic and side effects of this kind of medicine is often difficult to expect, once occur to be difficult to again make up.
Summary of the invention
Object of the present invention is exactly that provide a kind of Chinese medicine composition for the treatment of hysteromyoma, cost is low, evident in efficacy, has no side effect in order to overcome above-mentioned existing technical deficiency.
The technical scheme that the present invention solves the problems of the technologies described above employing is: a kind of Chinese medicine composition for the treatment of hysteromyoma, it is characterized in that the crude drug by weighing part is as follows made, Radix Angelicae Sinensis 13 ~ 18, Fructus Foeniculi 13 ~ 18, Rhizoma Corydalis 17 ~ 23, Rhizoma Chuanxiong 17 ~ 23, Radix Paeoniae Rubra 12 ~ 16, Pollen Typhae 3 ~ 7, Rhizoma Cyperi 3 ~ 7, Pseudobulbus Cremastrae Seu Pleiones 18 ~ 25, Flos Carthami 13 ~ 17, Myrrha 28 ~ 34, Radix Cyathulae 10 ~ 14, Fructus Alpiniae Oxyphyllae 14 ~ 16, Semen Strychni 14 ~ 16, Hedyotidis Diffusae 8 ~ 11, Oletum Trogopterori 10 ~ 13, Rhizoma Curcumae 28 ~ 34, Scorpio 8 ~ 12, the Radix Astragali 8 ~ 12, the Radix Linderae 13 ~ 17, Ramulus Cinnamomi 16 ~ 20, jujube nucleus 7 ~ 10, be soaked in water after above-mentioned 21 taste crude drug are mixed, to remove slag after decocting to obtain filtrate.
Beneficial effect of the present invention is that cost is low, evident in efficacy, has no side effect.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described:
Embodiment 1:
Adopt Radix Angelicae Sinensis, Fructus Foeniculi, Rhizoma Corydalis, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Pollen Typhae, Rhizoma Cyperi, Pseudobulbus Cremastrae Seu Pleiones, Flos Carthami, Myrrha, Radix Cyathulae, Fructus Alpiniae Oxyphyllae, Semen Strychni, Hedyotidis Diffusae, Oletum Trogopterori, Rhizoma Curcumae, Scorpio, the Radix Astragali, the Radix Linderae, Ramulus Cinnamomi, jujube nucleus is that crude drug is prepared from, and its component (with parts by weight) is: Radix Angelicae Sinensis 15, Fructus Foeniculi 15, Rhizoma Corydalis 20, Rhizoma Chuanxiong 18, Radix Paeoniae Rubra 14, Pollen Typhae 5, Rhizoma Cyperi 6, Pseudobulbus Cremastrae Seu Pleiones 22, Flos Carthami 15, Myrrha 31, Radix Cyathulae 13, Fructus Alpiniae Oxyphyllae 15, Semen Strychni 15, Hedyotidis Diffusae 10, Oletum Trogopterori 12, Rhizoma Curcumae 30, Scorpio 11, the Radix Astragali 10, the Radix Linderae 15, Ramulus Cinnamomi 17, jujube nucleus 9, getting above-mentioned 21 taste crude drug gross weights is 270 grams, is at room temperature added by 21 taste crude drug and purifies waste water 1000 milliliters, soaks 5-6 hour, then boil slow fire with high heat and decoct about 100-120 minute, remove slag to obtain filtrate 120 milliliters, medicinal residues add water 300 milliliters again, decoct 30-40 minute, to remove slag to obtain filtrate 80 milliliters, be total to obtain 200 milliliters of medicine juice, i.e. obtained Chinese medicine decoction of the present invention, (medicine) being taken before meal 200ml.
Chinese angelica blood supplementing of the present invention, invigorates blood circulation, and menstruction regulating and pain relieving moisturizes laxation.The all cards of main blood deficiency, menoxenia, amenorrhea, dysmenorrhea, lump in the abdomen knot is poly-; Fructus Foeniculi is used for colic of cold type stomachache, the testis swelling and hanging down of either of the testes, dysmenorrhea, few abdomen cold type of pain, abdominal distention, lack of appetite and vomiting; Rhizoma Corydalis is used for whole body each portion qi depression to blood stasis pain, dysmenorrhea, amenorrhea, lump in the abdomen, postpartum stagnation; Regulating menstruation water under Rhizoma Chuanxiong, middle relieving stagnation, controls blood stasis amenorrhea, dysmenorrhea; Radix Paeoniae Rubra has clearing away heat and cooling blood, effect of blood circulation promoting and blood stasis dispelling; Pollen Typhae is used for spitting blood, epistaxis, spitting of blood, metrorrhagia, traumatic hemorrhage, and amenorrhea stimulates the menstrual flow; Rhizoma Cyperi dispersing the stagnated live-QI to relieve the stagnation of QI, regulating the flow of QI to ease the stomach, menstruction regulating and pain relieving; The effects such as Pseudobulbus Cremastrae Seu Pleiones has heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation, are usually used in carbuncle furunculosis, scrofula sucutaneous nodule, snake bite and insect sting, lame abdominal mass mass in the abdomen; Flos Carthami promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain, contributes to controlling amenorrhea, dysmenorrhea, lochia, obstruction of qi in the chest and cardialgia, the stagnant stomachache of the stasis of blood; Myrrha has dissipating blood stasis analgesic therapy, effect of detumescence and promoting granulation.Be usually used in obstruction of qi in the chest and cardialgia, gastralgia, dysmenorrhea amenorrhea, postpartum stagnation , mass in the abdomen is suffered from abdominal pain, rheumatic arthralgia, traumatic injury, the treatment of the diseases such as carbuncle skin infection; Radix Cyathulae is used for amenorrhea lump in the abdomen, retention of placenta, injury from falling down, rheumatic arthralgia, flaccidity of the lower limbs clonic spasm of the muscle, the cards such as hematuria stranguria with blood; Fructus Alpiniae Oxyphyllae the kidney warming controlling nocturnal emission with astringent drugs reducing urination, saliva is taken the photograph in warming the spleen appetizing; The excited stomach invigorating of Semen Strychni, detumescence poison, removing heat from blood.Cure mainly numb limbs and tense tendons, paralysis, inappetence, mass in the abdomen, carbuncle pyogenic infections from tumour or sore, laryngopharynx swelling and pain; Hedyotidis Diffusae heat-clearing and toxic substances removing, medicinal powder for relieving pain knot, promoting urination to remove dampness.Outstanding kind treatment all kinds inflammation; Oletum Trogopterori can be used for blood-stasis internal-depression, escape of blood from meridian hemorrhage, if woman uterine bleeding is through many, the purple polylith of color, stabbing pain of the lower abdomen; Scorpio endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain.For hemiplegia, tetanus disease, rheumatoid arthritis stubborn, migraine and general headache, skin infection, scrofula; The circulation of qi promoting of Rhizoma Curcumae removing blood stasis, removing food stagnancy pain relieving.For abdominal pain due to blood stasis, hepatosplenomegaly, trusted subordinate's distending pain, gather, women's blood stasis amenorrhea; The Radix Astragali has enhancing human body immunity function, protects the liver, diuresis, defying age, anti-stress, blood pressure lowering and antibacterial action more widely; The Radix Linderae is used for QI stagnated by cold, chest and abdomen swelling and pain, QI rising in reverse order dyspnea with rapid respiration, deficiency-cold in the urinary bladder, enuresis frequent micturition, hernia pain, through cold stomachache; Ramulus Cinnamomi diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, dispersing cold for relieving pain.Main exterior syndrome due to wind-cold, arthralgia due to cold-dampnes, extreme cold of the limbs, amenorrhea dysmenorrhea, lump in the abdomen lumps; The main trusted subordinate's cold and heat of jujube nucleus, pathogens agglomerating gas gathers, painful limbs, arthralgia chiefly caused by damp pathogen.Each efficacy of drugs is made by these drug regimens to produce synergism, altogether the effect of long memorial liver and qi, nourishing spleen kidney, blood circulation promoting and blood stasis dispelling.
The each raw material of the present invention also can the embodiment that mixes of ratio (weight portion) listed by according to the form below realize.Its processing technique is identical with embodiment 1.
Embodiment Radix Angelicae Sinensis Fructus Foeniculi Rhizoma Corydalis Rhizoma Chuanxiong Radix Paeoniae Rubra Pollen Typhae Rhizoma Cyperi Pseudobulbus Cremastrae Seu Pleiones Flos Carthami Myrrha Radix Cyathulae Fructus Alpiniae Oxyphyllae Semen Strychni Hedyotidis Diffusae Oletum Trogopterori Rhizoma Curcumae Scorpio The Radix Astragali The Radix Linderae Ramulus Cinnamomi Jujube nucleus
Two 13 18 17 23 12 7 3 25 13 34 10 16 14 11 10 34 8 12 13 20 7
Three 18 13 23 17 16 3 7 18 17 28 14 14 16 8 13 28 12 8 17 16 10
Four 14 17 19 22 13 4 6 24 14 29 12 15 15 10 11 29 9 11 16 17 8
The clinical trial carried out below in conjunction with my institute is done further the present invention, is described in detail:
1, physical data
Inventor collects the outpatients of gynecology of 75 patients with uterin leiomyomas altogether between in May ,-2015 in August, 2013, age 24-46 year, course of disease 1-2.Be divided at random: treatment group 50 example, matched group 25 example.Two groups of data there was no significant differences such as the course of disease, age, have comparability.
2, test method
2.1 Therapeutic Method
The oral danazol of matched group, takes according to its description.1 month course for the treatment of.
The decoction that oral the present embodiment for the treatment of group 1 is obtained, morning every day (medicine) being taken before meal 200ml, 1 month course for the treatment of.
2.2 observation items: menoxenia before and after patient treatment, abdominal part are swollen and accompany bearing down, leucorrhea is many and accompanies the symptoms such as abnormal flavour, lower abdomen falling inflation, aching pain in waist and back to carry out observed and recorded.Laboratory ultrasound diagnosis Uterine Leiomyoma situation.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Recovery from illness: clinical symptoms all disappears, the atrophy of ultrasound diagnosis hysteromyoma.Take a turn for the better: clinical symptom relief, ultrasound diagnosis hysteromyoma diameter diminishes or not regrowth.Invalid: clinical symptoms is without being clearly better or increasing the weight of, and ultrasound diagnosis hysteromyoma continues to grow up.
3.2 treatment statistical results are in table 1.
Table 1 liang group comparitive study
Group Number of cases Recovery from illness Take a turn for the better Invalid Total effective rate
Treatment group 50 41 7 2 96%
Matched group 25 8 13 4 84%

Claims (1)

1. treat the Chinese medicine composition of hysteromyoma for one kind, it is characterized in that: be made up of the crude drug weighing part as follows, Radix Angelicae Sinensis 13 ~ 18, Fructus Foeniculi 13 ~ 18, Rhizoma Corydalis 17 ~ 23, Rhizoma Chuanxiong 17 ~ 23, Radix Paeoniae Rubra 12 ~ 16, Pollen Typhae 3 ~ 7, Rhizoma Cyperi 3 ~ 7, Pseudobulbus Cremastrae Seu Pleiones 18 ~ 25, Flos Carthami 13 ~ 17, Myrrha 28 ~ 34, Radix Cyathulae 10 ~ 14, Fructus Alpiniae Oxyphyllae 14 ~ 16, Semen Strychni 14 ~ 16, Hedyotidis Diffusae 8 ~ 11, Oletum Trogopterori 10 ~ 13, Rhizoma Curcumae 28 ~ 34, Scorpio 8 ~ 12, the Radix Astragali 8 ~ 12, the Radix Linderae 13 ~ 17, Ramulus Cinnamomi 16 ~ 20, jujube nucleus 7 ~ 10, be soaked in water after above-mentioned 21 taste crude drug are mixed, to remove slag after decocting to obtain filtrate.
CN201510832754.8A 2015-11-26 2015-11-26 Uterine fibroid treating traditional Chinese medicine composition Pending CN105288486A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510832754.8A CN105288486A (en) 2015-11-26 2015-11-26 Uterine fibroid treating traditional Chinese medicine composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510832754.8A CN105288486A (en) 2015-11-26 2015-11-26 Uterine fibroid treating traditional Chinese medicine composition

Publications (1)

Publication Number Publication Date
CN105288486A true CN105288486A (en) 2016-02-03

Family

ID=55186763

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510832754.8A Pending CN105288486A (en) 2015-11-26 2015-11-26 Uterine fibroid treating traditional Chinese medicine composition

Country Status (1)

Country Link
CN (1) CN105288486A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105816759A (en) * 2016-05-18 2016-08-03 亳州市永博保健食品有限公司 Traditional Chinese medicine composition for treating uterine fibroid

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103301281A (en) * 2013-06-17 2013-09-18 王朴希 Traditional Chinese medicine for treating uterine fibroid and preparation method thereof
CN103599271A (en) * 2013-11-26 2014-02-26 孙元盛 Traditional Chinese medicine for treating hysteromyoma

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103301281A (en) * 2013-06-17 2013-09-18 王朴希 Traditional Chinese medicine for treating uterine fibroid and preparation method thereof
CN103599271A (en) * 2013-11-26 2014-02-26 孙元盛 Traditional Chinese medicine for treating hysteromyoma

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李云: "少腹逐瘀汤临证三则举隅", 《实用中医内科杂志》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105816759A (en) * 2016-05-18 2016-08-03 亳州市永博保健食品有限公司 Traditional Chinese medicine composition for treating uterine fibroid

Similar Documents

Publication Publication Date Title
CN104147508A (en) Traditional Chinese medicine composition for treating irregular menstruation
CN102626505B (en) Massaging paste based on Chinese medicinal herbs and preparation method thereof
CN104043022A (en) Traditional Chinese medicine composition for treating gynecologic inflammation
CN100584374C (en) Externally applied medicine bag for curing chronic pelvic inflammatory disease
CN105125807A (en) Traditional Chinese medicine combination for treating adolescent polycystic ovary syndromes
CN100525827C (en) Chinese-medicinal composition for treating difficult menstruation
CN104689179A (en) Traditional Chinese medicine composition for treatment of acute attack of gouty arthritis
CN103272189B (en) Medicine for curing gallstones
CN103908511A (en) Traditional Chinese medicine pill for treating chondroma and preparation method thereof
CN105288486A (en) Uterine fibroid treating traditional Chinese medicine composition
CN101085281A (en) Traditional Chinese medicine for curing chronic nephritis
CN105435121A (en) Shenzhu pharmaceutical composition for treating atrophic gastritis and application thereof
CN105079549A (en) Traditional Chinese medicine for treating lupus nephritis
CN104758377A (en) Orally-taken drug for treating pelvic inflammation and preparation method for orally-taken drug
CN100371016C (en) Chinese traditional medicine preparation for curing mastopathy in installments
CN104306872A (en) Traditional Chinese medicine for treating uterine fibroid
CN103845547A (en) Traditional Chinese medicine decoction for treating mumps
CN103536863B (en) A kind of Chinese medicine for the treatment of the infertile disease of obstruction of collaterals by blood stasis pattern of syndrome
CN102847123B (en) Drug for treating chronic pelvic inflammatory disease and preparation method of medicine
CN101085318A (en) Traditional Chinese medicine for treating nephrotic syndrome
CN105327299A (en) Medicine for treating idiopathic thrombocytopenic purpura
CN105688176A (en) Traditional Chinese medicine hot-compress salt bag containing semen plantaginis and mangnolia officinalis and preparation method thereof
CN104997975A (en) Traditional Chinese medicine for treating epigastric pain
CN104887933A (en) Medicine for curing accumulated damp-heat chronic pelvic inflammation
CN104306898A (en) Orally taken traditional Chinese medicine for treating hysteromyoma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160203

RJ01 Rejection of invention patent application after publication